entertainment -WSS

entertainment

author：focus 2025-09-06 03:28:07 - browse：7

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Longer MASH drug regimen improved liver, Akero study finds

focus

WSS

China dismisses criticism of top diplomat's comments appearing to push for race

For AI in health care standards, federal regulators join with industry group

Israel withdraws forces after 2

He's 19 months old and has one of the world’s rarest diseases

State of the Union pitch: Bigger Medicare drug price negotiations

Israel withdraws forces after 2

hotspot

entertainment

explore

The cancer drug shortage isn’t new — and neither are the solutions

5 shark bites reported on Long Island as officials deploy surveillance drones

The high cost of giving birth even with insurance

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

At least 13 dead in Texas as scorching temps continue

Why Talkspace is targeting Medicare, a tricky market

BioMarin wins approval for gene therapy to treat hemophilia A

Pregnant women don't need prenatal multivitamins, study concludes

Apple is now the first public company to be valued at $3 trillion

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

focus

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

Pope Francis asks Church to identify 21st

Pentagon will tighten controls on classified information after Discord leak

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

He's 19 months old and has one of the world’s rarest diseases

Israel withdraws forces after 2

hotspot

focus

leisure time

focus